Clinical Trials Browser

Phase 1/2 × Sarcoma × PM 01183 × Clear all

NCT05734066 2026-02-03

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Phase 1/2 Recruiting

60 enrolled

Sarcoma

Sarcoma, Sarcoma, Ewing

NCT05099666 2025-12-09

Lurbinectedin + Doxorubicin In Leiomyosarcoma

Phase 1/2 Active not recruiting

62 enrolled

Sarcoma

NCT02611024 2025-07-09

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

Phase 1/2 Completed

316 enrolled

CNSEndocrineGastrointestinalGynecologicNETOther solid neoplasmSarcomaThoracic

Gastro-enteropancreatic neuroendocrine tumor, Carcinoma, Ovarian Epithelial, Glioblastoma, Mesothelioma, Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Neuroendocrine Tumors